XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
about
Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradationTargeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesMolecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella.High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.Minute kinetics of proapoptotic proteins: BAX and Smac/DIABLO in living tumor cells revealed by homeostatic confocal microscopy.Novel therapies for Hodgkin Lymphoma.Role of Smac/DIABLO in cancer progression.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Inhibitor of apoptosis proteins in hematological malignancies.Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells.CD30: an important new target in hematologic malignancies.Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).Key regulators of apoptosis execution as biomarker candidates in melanomaDimethylfumarate induces apoptosis in human mast cells.Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing.Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6.Essential role of TAK1 in regulating mantle cell lymphoma survival.Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.Downregulation of xIAP expression by small interfering RNA inhibits cellular viability and increases chemosensitivity to methotrexate in human hepatoma cell line HepG2.Varying Dietary Levels of Molybdenum Inducing Cell Apoptosis of Spleen Under Cadmium Stress in Caprine.Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.Elevated XIAP expression alone does not confer chemoresistance.Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis proteinThe role of apoptosis in the pathology of pancreatic cancerSTAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.Immunocytochemical detection of XIAP in body cavity effusions and washes.Dissociation of Caspase-3 from SMAC:XIAP:Caspase-3Analysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study
P2860
Q24298097-A70EB5E4-738F-417C-8B48-24AE6254509EQ33415723-92BAEB9D-0558-4E40-B6A7-132D822A9213Q33571656-A45FA027-72E9-4E16-99AE-CBFB22239A73Q33886267-6D0B8EDE-2FED-43B7-9B1D-74F1CE646A59Q34480682-6BC51357-A6FB-4055-A815-2ED9D8DC14CDQ34806506-E28FADFA-4D70-4F53-A07E-2F5A3F5B0C37Q35782071-99BF020A-75BA-49B8-877A-7E020072C948Q35905166-FE24B28C-2831-4B68-841C-AC446F47C951Q35922424-10279B4B-9ED0-4DC3-A64F-7CBF6C2F6714Q36256139-3FF36751-921F-4B13-AEE7-2025CD6FF1A9Q36612532-DB0E1B61-043E-4A72-A208-5AFE65DC5E12Q36934716-09DE81C3-F3DC-4B10-BAC2-0065C01D251BQ37004635-5C832E71-BBC6-43E4-B916-AED0CA06DB38Q37016499-82AC035F-EC52-45B3-A4F4-5B5A5C459911Q37271829-CFF983BF-112D-4467-83A6-B7C0E6D21B3DQ37336610-419B7B72-1548-4074-94BF-C72180008644Q37622948-27B5C91F-AED4-46D0-8B07-77F0DA5EFF0DQ37880873-69B78651-0C6F-4E76-927D-9D33EEE52132Q37974461-F7804308-9B9D-4AC4-B9F8-896966188279Q38184343-1064FBBC-C3BA-45E2-9049-97571A4066EDQ38217477-5C4F00BA-FE8D-410B-8C7C-A20DE1C7AE72Q38866722-16FFEEDC-3AAA-4D74-96E7-F00D0310F7A8Q39083128-4451B6F3-8AEC-4D31-8A16-FE7E56136FE8Q39148654-44BEB97F-BB28-4CBA-839B-DD9E53720C2BQ39251334-AC7AC75E-EF86-4B61-A986-4EABA9440563Q39339382-DDF931C6-D779-49A9-9FAC-FE5FEF00E7F4Q39467184-7615FF05-BA3D-4D36-8EFA-81B8AEEFAE6DQ39772932-D71B3F3F-694E-42F4-93B8-9B3634ABB0D8Q40204261-C24F077B-8396-47EB-88B8-A33AE6D0D002Q40301042-BD698472-2A5C-4BDB-B787-9C5E4D968B92Q40463082-A16CBB44-20FA-4E57-BA31-009291F5698DQ40488705-1A7C78D4-B837-4AF9-82BE-B4E474141623Q40983623-B2E2B6B3-171C-4C4A-93FF-584A99A9642CQ41834899-9FD1F608-FD10-43E5-8D32-2F5FDFCF3941Q42212254-1D2F00C1-EAFD-4451-8EDD-2E6BFBA0279AQ46506090-5C8C456E-8967-49B8-8A7C-43198FC2BE55Q46666280-0D6D5EF6-CB99-4456-A65E-951BF207BA72Q50297358-AF27C0C3-FD07-4F8D-A192-5958F970B7BEQ58698930-918EC8E5-5BEB-45A9-B07E-CBA98701F42A
P2860
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@ast
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@en
type
label
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@ast
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@en
prefLabel
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@ast
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@en
P2093
P2860
P356
P1476
XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells
@en
P2093
Christiane Haefs
Guy S Salvesen
Hamid Kashkar
Hwain Shin
Juliane M Jurgensmeier
Martin Kronke
P2860
P304
P356
10.1084/JEM.20021279
P407
P577
2003-07-01T00:00:00Z